Beyond Biotech - the podcast from Labiotech cover image

Beyond Biotech podcast 53: Antibody-drug conjugates

Beyond Biotech - the podcast from Labiotech

00:00

Advancements in Antibody-Drug Conjugates (ADCs)

This chapter explores the current state and future potential of antibody-drug conjugates (ADCs) in cancer therapy. It discusses the advantages of ADCs, challenges in their development, and potential applications beyond cancer. The chapter also highlights the importance of demonstrating efficacy and improving safety profiles of ADCs.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app